sulfadoxine has been researched along with Cross Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arroyave, M; Blair, S; Franco, L; González, L; Maestre, A; Ochoa, J; Restrepo, E | 1 |
| Boctor, F | 1 |
2 other study(ies) available for sulfadoxine and Cross Infection
| Article | Year |
|---|---|
Nosocomial Plasmodium falciparum infections confirmed by molecular typing in Medellín, Colombia.
Topics: Adult; Animals; Antigens, Protozoan; Colombia; Cross Infection; Drug Combinations; Equipment Contamination; Fatal Outcome; Genotype; Humans; Malaria, Falciparum; Male; Merozoite Surface Protein 1; Middle Aged; Plasmodium falciparum; Polymerase Chain Reaction; Protozoan Proteins; Pyrimethamine; Quinine; Sulfadoxine | 2005 |
Sulfadoxine-pyrimethamine as an anti-malaria preventative in donated blood.
Topics: Antimalarials; Blood Donors; Cross Infection; Drug Approval; Drug Combinations; Global Health; Humans; Malaria; Pyrimethamine; Sulfadoxine; United States; United States Food and Drug Administration | 2006 |